ArticleCancers2026

Treatment Sequencing of CDK4/6 Inhibitors in Bone-Only Hormone Receptor-Positive Metastatic Breast Cancer: Multi-Center Real-World Data Revealing a Numerical Trend Favoring Later-Line Use.

Serkan Yıldırım et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.